Search


 
Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 159 (Search time: 0.002 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
Oct-2009Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.Rudinskiy, N; Kaneko, YA; Beesen, AA; Gokce, O; Régulier, E; Déglon, N; Luthi-Carter, RJournal Article
Aug-2010Developmental expression of Synaptotagmin isoforms in single calyx of Held-generating neurons.Xiao, L; Han, Y; Runne, H; Murray, H; Kochubey, O; Luthi-Carter, R; Schneggenburger, RJournal Article
15-Apr-2010Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.Becanovic, K; Pouladi, MA; Lim, RS; Kuhn, A; Pavlidis, P; Luthi-Carter, R; Hayden, MR; Leavitt, BRJournal Article
Dec-2006P2X1 receptors mediate sympathetic postjunctional Ca2+ transients in mesenteric small arteries.Lamont, C; Vial, C; Evans, RJ; Wier, WGJournal Article
Aug-2004Renal autoregulation in P2X1 knockout mice.Inscho, EW; Cook, AK; Imig, JD; Vial, C; Evans, RJJournal Article
Oct-2001The KATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation.Lawrence, CL; Billups, B; Rodrigo, GC; Standen, NBJournal Article
Mar-2001Nerve evoked P2X receptor contractions of rat mesenteric arteries; dependence on vessel size and lack of role of L-type calcium channels and calcium induced calcium release.Gitterman, DP; Evans, RJJournal Article
15-Oct-2009Plasmin-mediated degradation of laminin gamma-1 is critical for ethanol-induced neurodegeneration.Skrzypiec, AE; Maiya, R; Chen, Z; Pawlak, R; Strickland, SJournal Article
Nov-2007PERK in the life and death of the pancreatic beta-cell.Herbert, TPJournal Article
1-Aug-2007Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.Kuhn, A; Goldstein, DR; Hodges, A; Strand, AD; Sengstag, T; Kooperberg, C; Becanovic, K; Pouladi, MA; Sathasivam, K; Cha, JH; Hannan, AJ; Hayden, MR; Leavitt, BR; Dunnett, SB; Ferrante, RJ; Albin, R; Shelbourne, P; Delorenzi, M; Augood, SJ; Faull, RL; Olson, JM; Bates, GP; Jones, L; Luthi-Carter, RJournal Article